Zydus Wellness has dipped over 6% to Rs 575, extending its Monday’s 6% fall on NSE, after reporting a 25% year-on-year decline in consolidated net profit of Rs 17 crore for the first quarter ended June 30, due to lower operational income. The company had registered a profit of Rs 23 crore in the corresponding period last year.
Company’s net sales declined 5.6% to Rs 101 crore during the quarter under review against Rs 108 crore in the same period last year.
Zydus Wellness manufactures healthcare products like Sugar Free, Nutralite and EverYuth.
The stock opened at Rs 606 and touched a low of Rs 569 on NSE. A combined around 84,000 shares changed hands on the counter so far on NSE and BSE.
Company’s net sales declined 5.6% to Rs 101 crore during the quarter under review against Rs 108 crore in the same period last year.
Zydus Wellness manufactures healthcare products like Sugar Free, Nutralite and EverYuth.
The stock opened at Rs 606 and touched a low of Rs 569 on NSE. A combined around 84,000 shares changed hands on the counter so far on NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%